Latest DiaSys news - 2020/02
September, 2020
Dear customers, dear friends,
As a new and fast-progressing disease, COVID-19 has become the focus of attention around the world in recent months. Over the past months, DiaSys has provided information on DiaSys products for monitoring patients with COVID-19 infection. Additional important information will follow in the coming weeks, including an extraordinary highlight since DiaSys is currently developing a new assay to measure antibodies in the course of a COVID-19 infection.

Find out more
 
COMPANY
DiaSys goes online
We used the time of standstill to transform our face-to-face training courses into location-independent live online training.

Find out more
Successful installation of the first respons®940 analyzer in Algeria
Our distributor Hospic Sarl in Algeria, located 300 kilometers east of Algiers, has received its first respons®940 analyzer despite the corona-related lockdown.

Find out more
DiaSys welcomes the Minister of Economics of Rhineland-Palatinate
As part of his summer trip to companies in the federal state of Rhineland-Palatinate, the Minister of Economic Affairs, Dr. Volker Wissing, visited DiaSys in Holzheim.

Find out more
Invitation to register for internal part of website
Our distributors can register on our website to get access to more relevant information and documents. 

Register here
 
PRODUCTS
 Outstanding performance of DiaSys PCT FS - scientifically proven
In July 2020, five months after the product launch, Dupuy (et al.) published the first peer-reviewed publication on Procalcitonin FS in the MDPI journal Diagnostics.

Find out more
 DiaSys publication at ABC Journal
In cooperation with Fresenius University of Applied Sciences in Idstein and the Technical University of Darmstadt, DiaSys has published an article in the journal Analytical and Bioanalytical Chemistry about the standardization of HbA1c.

Find out more
 New Reagent for Direct Determination of HDL-cholesterol
DiaSys is pleased to offer HDL-c direct FS, a new homogenous assay for direct determination of HDL-cholesterol (HDL-C).

Find out more
 DiaSys new water purification systems
DiaSys is proud to present its new water purification systems: O classic, O mini and O maxi. The accuracy and reliability of results depend to a large extent on the quality of the process water.

Find out more
 
BLOG
New article series: How COVID-19 Impacts the Body
After the first blog article series about DiaSys parameters in Covid-19 monitoring, we will now take a closer look at how COVID-19 impacts the body. Understanding how the virus impacts the body helps to find and monitor treatment, but as well helps to identify and diagnose patients that have no access to PCR.

View all articles
If you have any questions or suggestions please contact: dialog@diasys.de

Executive board:
Dr. Günther Gorka,
Dr. Jan Gorka,
Peter Zöller
DiaSys Diagnostic Systems GmbH
Alte Strasse 9 | 65558 Holzheim | DE

Fon: +49 (0) 64 32 - 91 46-0
Fax: +49 (0) 64 32 - 91 46-32
Register court: AG Montabaur
Registration number: HRB 7106

Sales tax identification number according to
§ 27 a VAT registration number: DE 148-404-658